EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients

Zainab Assy iD, William Murray Thomson iD, Henk S Brand, Seunghee Cha, Merve M Susam iD, Gary A Weisman iD, Arjan Vissink iD, Floris J Bikker iD, Derk Hendrik Jan Jager iD

Oral Diseases · 2024-10 · 30 (7) · 4356-4363

DOI: 10.1111/odi.14841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 26.12.2023. Verfasst von Zainab Assy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherl…. Hauptthemen laut MEDLINE: Xerostomia, Sjogren's Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Until now, the clinically relevant improvement for the Xerostomia Inventory (XI) has not been defined. Therefore, our aim was to determine the Minimally Important Difference (MID) of the XI for improvement in dry‐mouth symptoms in SjD patients.

Method

The study recruited 34 SjD patients who underwent sialendoscopy of major salivary glands and 15 SjD patients in a nonintervention control group. XI scores were assessed at several time points. The MID was determined from the mean difference in XI scores between the groups with and without improvement.

Results

In the control group, no significant XI score changes were seen. In the sialendoscopy group, a clinically relevant XI score change of four scale points was identified after 1 week. For a prolonged duration (≥16 weeks), a minimum reduction of seven scale points in the XI score was required to indicate clinically relevant improvement.

Conclusion

In SjD patients, a minimum change of four points in the XI score indicates a clinically relevant improvement for evaluating short‐term effects. For prolonged effects, a clinically relevant improvement requires a MID of seven points. The determination of the MID in XI could assist in future studies that evaluate changes in xerostomia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XerostomiaSjogren's SyndromeHumansFemaleMiddle AgedMaleAgedEndoscopyAdultCase-Control StudiesMinimal Clinically Important Difference

Stichwörter der Autor:innen

Sjögren's syndromeXerostomia Inventoryclinical trialsendpoint determinationpatient reported outcome measuresxerostomia

Autor:innen und Institutionen

  • Department of Oral Biochemistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.
  • Sir John Walsh Research Institute, University of Otago Faculty of Dentistry, Dunedin, New Zealand.
  • Department of Oral and Maxillofacial Diagnostic Sciences, Center for Orphaned Autoimmune Disorders, University of Florida, Gainesville, Florida, USA.
  • Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Biochemistry, Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
  • Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Zainab Assy, William Murray Thomson, Merve M Susam, Gary A Weisman, Arjan Vissink, Floris J Bikker, Derk Hendrik Jan Jager

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Assy, Z., Thomson, W. M., Brand, H. S., Cha, S., Susam, M. M., Weisman, G. A., Vissink, A., Bikker, F. J., & Jager, D. H. J. (2024). The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients. Oral Diseases, 30(7), 4356-4363. https://doi.org/10.1111/odi.14841

Vancouver

Assy Z, Thomson WM, Brand HS, Cha S, Susam MM, Weisman GA, et al. The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients. Oral Diseases. 2024;30(7):4356-4363. doi:10.1111/odi.14841

BibTeX
@article{Assy2024,
  author = {Assy, Zainab and Thomson, William Murray and Brand, Henk S and Cha, Seunghee and Susam, Merve M and Weisman, Gary A and Vissink, Arjan and Bikker, Floris J and Jager, Derk Hendrik Jan},
  title = {The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients},
  journal = {Oral Diseases},
  year = {2024},
  volume = {30},
  number = {7},
  pages = {4356--4363},
  doi = {10.1111/odi.14841}
}
Kostenlos starten →